2018 annual financial data

Revelation Biosciences 2018 Net margin

Revelation Biosciences 2018 net margin with verified reported values.

Direct answer

Net margin was 32.46%.

Operating income was 38,894,000 USD and net income was 27,627,000 USD.
Operating cash flow was 32,579,000 USD.

Get free Revelation Biosciences email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
85,113,000 USD
Operating income
38,894,000 USD
Net income
27,627,000 USD
Operating cash flow
32,579,000 USD